Clinical outcomes of dental implants in head and neck cancer patients: An overview

Imagem de Miniatura
Arquivos
art_MARQUES_Clinical_outcomes_of_dental_implants_in_head_and_2023.PDF (1.32 MB)
Citações na Scopus
3
Tipo de produção
article
Data de publicação
2023
DOI
Scopus
Web of Science
PubMed
Título da Revista
ISSN da Revista
Título do Volume
Editora
ELSEVIER SCIENCE INC
Autores
MARQUES, Nelson Pereira
PEREZ-DE-OLIVEIRA, Maria Eduarda
NORMANDO, Ana Gabriela Costa
MARQUES, Nadia Carolina Teixeira
EPSTEIN, Joel B.
MIGLIORATI, Cesar A.
MARTELLI JUNIOR, Hercilio
Citação
ORAL SURGERY ORAL MEDICINE ORAL PATHOLOGY ORAL RADIOLOGY, v.136, n.1, p.42-53, 2023
Projetos de Pesquisa
Unidades Organizacionais
Fascículo
Resumo
Objective. The aim of this study was to evaluate the clinical outcomes of dental implants (DIs) in patients with head and neck can-cer (HNC) treated with radiotherapy (RT), isolated chemotherapy, or bone modifying agents (BMAs). Study Design. This study was registered in the Prospective Register of Systematic Reviews (CRD42018102772); conducted via the Preferred Reporting Items for Systematic Reviews and Meta-Analyses checklist; and based on PubMed, Scopus, Embase, Cochrane Library, Web of Science, and gray literature searches. The selection of studies was performed in 2 phases by 2 independent reviewers. The risk of bias (RoB) was assessed by the Measurement Tool to Assess the Methodological Quality of Systematic Reviews 2. Results. Twenty systematic reviews were included in the qualitative analysis. The majority scored as having high RoB (n = 11). Pri-mary DIs placement in the mandible of patients with HNC subjected to RT doses <50 Gy was associated with better survival rates. Conclusions. The placements of DIs could be considered safe in patients with HNC in sites of alveolar bone that received RT (<5000 Gy); however, no conclusions could be made in patients with cancer managed by chemotherapy or BMAs. Due to the heterogeneity of studies included, the recommendation for DIs placement in patients with cancer should be carefully considered. Future better controlled randomized clinical trials are required to provide enhanced clinical guidelines for best patient care. (Oral Surg Oral Med Oral Pathol Oral Radiol 2023;136:42-53)
Palavras-chave
URI
https://observatorio.fm.usp.br/handle/OPI/56245
Referências
  1. Alberga JM, 2021, ORAL DIS, V27, P94, DOI 10.1111/odi.13312
  2. Aromataris E, 2015, INT J EVID-BASED HEA, V13, P132, DOI 10.1097/XEB.0000000000000055
  3. Barber AJ, 2011, BRIT J ORAL MAX SURG, V49, P29, DOI 10.1016/j.bjoms.2009.12.007
  4. Chambrone L, 2013, J DENT RES, V92, p119S, DOI 10.1177/0022034513504947
  5. Chen H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071955
  6. Chrcanovic BR, 2014, J ORAL REHABIL, V41, P443, DOI 10.1111/joor.12157
  7. Chrcanovic BR, 2016, IMPLANT DENT, V25, P261, DOI 10.1097/ID.0000000000000388
  8. Chrcanovic BR, 2016, HEAD NECK-J SCI SPEC, V38, P448, DOI 10.1002/hed.23875
  9. Chrcanovic BR, 2010, ORAL MAXILLOFAC SURG, V14, P81, DOI 10.1007/s10006-010-0205-1
  10. Chrcanovic BR, 2010, ORAL MAXILLOFAC SURG, V14, P3, DOI 10.1007/s10006-009-0198-9
  11. Claudy MP, 2015, CLIN IMPLANT DENT R, V17, P402, DOI 10.1111/cid.12096
  12. Colella G, 2007, INT J ORAL MAX IMPL, V22, P616
  13. COOPER JS, 1995, INT J RADIAT ONCOL, V31, P1141, DOI 10.1016/0360-3016(94)00421-G
  14. Duttenhoefer F, 2019, INT J IMPLANT DENT, V5, DOI 10.1186/s40729-019-0191-5
  15. Grant MJ, 2009, HEALTH INFO LIBR J, V26, P91, DOI 10.1111/j.1471-1842.2009.00848.x
  16. Grotz KA, 2012, BISPHOSPHONAT ASSOZI
  17. Hunt H, 2018, SYST REV-LONDON, V7, DOI 10.1186/s13643-018-0695-8
  18. Kim DD, 2011, ORAL MAXIL SURG CLIN, V23, P337, DOI 10.1016/j.coms.2011.01.006
  19. Kotsakis GA, 2015, CLIN IMPLANT DENT R, V17, P598, DOI 10.1111/cid.12240
  20. Koudougou C, 2020, HEAD NECK-J SCI SPEC, V42, P794, DOI 10.1002/hed.26065
  21. Marques NP, 2021, PROSPERO
  22. Moher D, 2009, PLOS MED, V6
  23. NGUYEN TD, 1988, INT J RADIAT ONCOL, V14, P23, DOI 10.1016/0360-3016(88)90045-4
  24. Nobrega AS, 2016, J PROSTHET DENT, V116, P858, DOI 10.1016/j.prosdent.2016.04.025
  25. Nooh N, 2013, INT J ORAL MAX IMPL, V28, P1233, DOI 10.11607/jomi.3045
  26. Ouzzani M, 2016, SYST REV-LONDON, V5, DOI 10.1186/s13643-016-0384-4
  27. Salinas TJ, 2010, J ORAL MAXIL SURG, V68, P524, DOI 10.1016/j.joms.2009.09.104
  28. Schiegnitz E, 2015, CLIN ORAL INVEST, V19, P1693, DOI 10.1007/s00784-015-1508-2
  29. Schimmel M, 2018, CLIN ORAL IMPLAN RES, V29, P311, DOI 10.1111/clr.13288
  30. Schmitt CM, 2018, EUR J ORAL IMPLANTOL, V11, pS93
  31. Schoen PJ, 2007, INT J PROSTHODONT, V20, P469
  32. Shea BJ, 2017, BMJ-BRIT MED J, V358, DOI 10.1136/bmj.j4008
  33. Shugaa-Addin Bassam, 2016, J Clin Exp Dent, V8, pe194, DOI 10.4317/jced.52346
  34. Skeel RT, 2011, HDB CANC CHEMOTHERAP, V8th, P832
  35. Veld MI', 2021, CURR OPIN OTOLARYNGO, V29, P126, DOI 10.1097/MOO.0000000000000685
  36. Verdonck HWD, 2008, CLIN ORAL IMPLAN RES, V19, P201, DOI 10.1111/j.1600-0501.2007.01457.x
  37. Walter C, 2016, INT J IMPLANT DENT, V2, DOI 10.1186/s40729-016-0041-7
  38. Walter C, 2014, CLIN ORAL INVEST, V18, P2221, DOI 10.1007/s00784-014-1205-6
  39. Walter C, 2014, CLIN ORAL INVEST, V18, P385, DOI 10.1007/s00784-013-0974-7
  40. Walter C, 2010, HEAD FACE MED, V6, DOI 10.1186/1746-160X-6-11
  41. Young DR, 1997, J BONE MINER RES, V12, P1874, DOI 10.1359/jbmr.1997.12.11.1874
  42. Zen EV, 2016, HEAD NECK-J SCI SPEC, V38, pE2229, DOI 10.1002/hed.24098

Coleções
Artigos e Materiais de Revistas Científicas - HC/ICESP
Artigos e Materiais de Revistas Científicas - HC/ICHC
Artigos e Materiais de Revistas Científicas - ODS/03